Bellicum Pharmaceuticals' Grant

Bellicum Pharmaceuticals raised a round of funding on March 25, 2011. Investors include Cancer Prevention and Research Institute of Texas.

Bellicum Pharmaceuticals is developing stem cell transplant, TCR, and CAR T cell therapies. Its product candidates incorporate molecular switches designed to allow activation or elimination of therape…

Articles about Bellicum Pharmaceuticals' Grant: